Is It Too Late to Buy ChemoCentryx Stock?
On July 7, biotech ChemoCentryx(NASDAQ:CCXI) will be undergoing an event that could make or break its stock price. Its flagship drug candidate, avacopan, an oral molecule under investigation for the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated…
